Case File
efta-efta00672143DOJ Data Set 9OtherFrom: "Barrett, Paul S"
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00672143
Pages
3
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Barrett, Paul S"
To: Jeffrey Epstein <[email protected]>
Subject: RE: Swap idea
Date: Mon, 02 Apr 2012 15:41:34 +0000
Can I do the switch into Meritor?
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(W)
(F)
NMLS ID#
From: Jeffrey Epstein (malitoleevacation@gmalloom]
Sent: Monday, April 02, 2012 11:40 AM
To: Barrett, Paul S
Subject: Re: Swap idea
ok sell them
On Mon, Apr 2, 2012 at 11:38 AM, Barrett, Paul S <
• wrote:
All in +$180,000 (136K from interest and 46K from capital appreciation)
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
JPMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(W)
(F)
From: Jeffrey Epstein [mailto:[email protected]
Sent: Monday, April 02, 2012 11:35 AM
To: Barrett, Paul S
Subject: Re: Swap Idea
p & 1 for the fords?
On Mon, Apr 2, 2012 at 11:24AM, Barrett, Paul S <
Hi Jeffrey
• wrote:
EFTA00672143
I think we should sell our $1.2MM of the Ford 7% 2015 (ytm 3.82%) and move into a 3yr Meritor Note yielding 6%.
Meritor is a global auto parts supplier focused on commercial parts. We are OW the credit. I would recommend $1.5MM
of this.
Let me know.
Paul
Paul Barrett, CFA
Managing Director
Global Investment Opportunities Group
3PMorgan Private Bank
320 Park Avenue, 14th Floor, New York, NY 10022
(F)
NMLS IDu
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.corn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://wwwjpmorgan.corn/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
EFTA00672144
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This email is confidential and subject to important disclaimers and conditions including on offers for the
purchase or sale of securities, accuracy and completeness of information, viruses, confidentiality, legal privilege,
and legal entity disclaimers, available at http://www.jpmorgan.corn/pages/disclosures/email.
EFTA00672145
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]URL
http://www.jpmorgan.corn/pages/disclosures/emailURL
http://wwwjpmorgan.corn/pages/disclosures/emailRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.